Astellas to Acquire Propella Therapeutics
- Acquire PRL-02, prostate cancer treatment program being developed by Propella Therapeutics - TOKYO and PITTSBORO, N.C., Nov. 15, 2023 /PRNewswire/ -- Astellas Pharma Inc. and Propella...
Stay updated with breaking news from William Moore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Acquire PRL-02, prostate cancer treatment program being developed by Propella Therapeutics - TOKYO and PITTSBORO, N.C., Nov. 15, 2023 /PRNewswire/ -- Astellas Pharma Inc. and Propella...
If Propella’s PRL-02 proves to be effective and wins approval, it would provide Astellas with yet another contender against Zytiga, which once brought in nearly $2 billion in revenue for Johnson & Johnson.
/PRNewswire/ -- The Eleanor Crook Foundation (ECF) has made a $1.2 million investment in Helen Keller Intl to introduce Multiple Micronutrient Supplementation...
Multiple Micronutrient Supplements hold promise to improve nutrition care for pregnant women and help the next generation survive and thrive WASHINGTON, Nov. 15, 2023 /PRNewswire/ -- The Eleanor Crook Foundation (ECF)
The Eleanor Crook Foundation (ECF) has made a $1.2 million investment in Helen Keller Intl to introduce Multiple Micronutrient Supplementation (MMS) to pregnant women in Nepal to advance implementation research. This project is in service of the...